Seroepidemiology of hepatitis A and hepatitis B virus in Luxembourg

Epidemiology and Infection

Volumn 134, Issue 4, 2006, Pages 808-813

  Mossong, J ^a,b   Putz, L ^a,b   Patiny, S ^a   Schneider, F ^a  

^a LABORATOIRE NATIONAL DE SANTÉ   (Luxembourg)

^b LUXEMBOURG INSTITUTE OF HEALTH   (Luxembourg)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS A ANTIBODY; HEPATITIS A ANTIGEN; HEPATITIS B ANTIBODY; HEPATITIS B CORE ANTIGEN; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE; VIRUS ANTIGEN;

ADOLESCENT; ADULT; AGED; ANTIBODY SCREENING; ARTICLE; CHEMOLUMINESCENCE; CHILD; CLINICAL ASSESSMENT; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; DRUG EXPOSURE; FEMALE; GROUPS BY AGE; HEALTH PROMOTION; HEALTH SURVEY; HEPATITIS A; HEPATITIS A VIRUS; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; IMMIGRANT; INDIVIDUALITY; INFANT; INFECTION SENSITIVITY; LUXEMBOURG; MAJOR CLINICAL STUDY; MALE; MICROPARTICLE ENZYME IMMUNOASSAY; POPULATION RESEARCH; PORTUGAL; PROSPECTIVE STUDY; QUANTITATIVE ANALYSIS; SEROEPIDEMIOLOGY; SEROPREVALENCE; STANDARDIZATION; YUGOSLAVIA;

EID: 33745520397     PISSN: 09502688     EISSN: 14694409     Source Type: Journal    
DOI: 10.1017/S0950268805005789     Document Type: Article

References (21)

1. Webster G, et al. Protecting travellers from hepatitis A. British Medical Journal 2001; 322: 1194-1195.
2. Furusyo N, et al. The elimination of hepatitis B virus infection: changing seroepidemiology of hepatitis A and B virus infection in Okinawa, Japan over a 26-year period. American Journal of Tropical Medicine and Hygiene 1998; 59: 693-698.
3. Lemon SM, Thomas DL. Vaccines to prevent viral hepatitis. New England Journal of Medicine 1997; 336: 196-204.
4. Mossong J, Putz L, Schneider F. Seroprevalence of measles, mumps and rubella antibodies in Luxembourg: Results from a national cross-sectional study. Epidemiology and Infection 2004; 132: 11-18.
5. Mossong J, Putz L, Schneider F. Seroprevalence and force of infection of varicella-zoster virus in Luxembourg. Epidemiology and Infection 2004; 132: 1121-1127.
6. Mossong J, et al. Seroepidemiology of diphtheria and pertussis in Luxembourg in 2000. Epidemiology and Infection 2005. Published online 29 November 2005;
7. Edmunds WJ, et al. The sero-epidemiology of diphtheria in Western Europe. ESEN Project. European Sero-Epidemiology Network. Epidemiology and Infection 2000; 125: 113-125.
8. Service central de la statistique et des études économiques. Annual statistics. Luxembourg, 2003.
9. Hutin YJ, et al. A multistate, foodborne outbreak of hepatitis A. National Hepatitis A Investigation Team. New England Journal of Medicine 1999; 340: 595-602.
10. Gay NJ, et al. Age-specific antibody prevalence to hepatitis A in England: Implications for disease control. Epidemiology and Infection 1994; 113: 113-120.
11. Beutels M, et al. The shift in prevalence of hepatitis A immunity in Flanders, Belgium. Acta Gastro-Enterologica Belgica 1998; 61: 4-7.
12. Nemecek V, et al. The 2001 serological survey in the Czech Republic - viral hepatitis. Central European Journal of Public Health 2003; 11: S54-S61.
13. Chapman BA, et al. The prevalence of viral hepatitis (HAV, HBV and HCV) in the Christchurch community. New Zealand Medical Journal 2000; 113: 394-396.
14. Morris-Cunnington MC, et al. A population-based seroprevalence study of hepatitis A virus using oral fluid in England and Wales. American Journal of Epidemiology 2004; 159: 786-794.
15. Cunha I, Antunes H. Prevalence of antibodies against hepatitis A virus in a population from northern Portugal [in Portuguese]. Acta Medica Portuguesa 2001; 14: 479-482.
16. Direction de la Santé. Vaccine coverage survey in the Grand Duchy of Luxembourg. Jan.-Feb. 2002 [in French].
17. Al-Faleh FZ, et al. Seroepidemiology of hepatitis B virus infection in Saudi children 8 years after a mass hepatitis B vaccination programme. Journal of Infection 1999; 38: 167-170.
18. Bonanni P, et al. Impact of routine infant and adolescent hepatitis B vaccination in Tuscany, Central Italy. Pediatric Infectious Disease Journal 1999; 18: 677-682.
19. Coates T, et al. Hepatitis B vaccines: Assessment of the seroprotective efficacy of two recombinant DNA vaccines. Clinical Therapeutics 2001; 23: 392-403.
20. Thierfelder W, et al. Prevalence of markers for hepatitis A, B and C in the German population. Results of the German National Health Interview and Examination Survey 1998. European Journal of Epidemiology 2001; 17: 429-435.
21. Beutels M, et al. Prevalence of hepatitis A, B and C in the Flemish population. European Journal of Epidemiology 1997; 13: 275-280.